Maarbjerg and Jeanett Borregaard were employees of Novo Nordisk A/S at the time of conduct of the trial and preparation of this manuscript and are shareholders of Novo Nordisk A/S (current affiliation of SJM: Zealand Pharma A/S, Sborg, Denmark
A Conceptual Model of Food Cue Reactivity - PMC - PubMed Central, accessed April 22, 2025, GLP1 receptor agonists for the treatment of obesity: Role as a promising approach, accessed April 22, 2025, GLP-1 and the Neurobiology of Eating Control: Recent Advances - Oxford Academic, accessed April 22, 2025, pmc.ncbi.nlm.nih.gov, accessed April 22, 2025, Taking a GLP-1
One dietary difference in the activation of mast cells in obesity (in animal studies) is cholesterol levels
This approach offers a more direct assessment of erythrocytosis
These medications are a fantastic tool for weight management
Approximately 1.6 million people worldwide died as a direct result of diabetes in 2016, according to the World Health Organization (WHO)